BR9809713A - Composto, medicamento e composição compreendendo o mesmo, uso do composto, e, processos para profilaxia ou tratamento de doenças mediadas com taquicinina, para inibir um receptor nk1 e/ou um receptor nk2, e para profilaxia ou tratamento de asma e/ou bronquite, de rinite, de alergia, e, de incontinência urinária - Google Patents

Composto, medicamento e composição compreendendo o mesmo, uso do composto, e, processos para profilaxia ou tratamento de doenças mediadas com taquicinina, para inibir um receptor nk1 e/ou um receptor nk2, e para profilaxia ou tratamento de asma e/ou bronquite, de rinite, de alergia, e, de incontinência urinária

Info

Publication number
BR9809713A
BR9809713A BR9809713-0A BR9809713A BR9809713A BR 9809713 A BR9809713 A BR 9809713A BR 9809713 A BR9809713 A BR 9809713A BR 9809713 A BR9809713 A BR 9809713A
Authority
BR
Brazil
Prior art keywords
compound
prophylaxis
receptor
treatment
composition
Prior art date
Application number
BR9809713-0A
Other languages
English (en)
Inventor
Takahide Nishi
Takeshi Yamaguchi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of BR9809713A publication Critical patent/BR9809713A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

''COMPOSTO, MEDICAMENTO, COMPOSIçãO, E, USO DO COMPOSTO'' Cloridrato ou fumarato de 1-{2-[(2R)-3,4-diclorofenil)-4-(3,4,5-trimetoxibenzoil)morfolin-2-il]etil}e spiro[benzo[c]tiofeno-1(3H),4'-piperidin]-(2S)-óxido tendo uma boa capacidade de absorção oral e atividades antagonísticas notáveis para ambos os receptores NK~ 1~ e NK~ 2~.
BR9809713-0A 1997-05-30 1998-05-27 Composto, medicamento e composição compreendendo o mesmo, uso do composto, e, processos para profilaxia ou tratamento de doenças mediadas com taquicinina, para inibir um receptor nk1 e/ou um receptor nk2, e para profilaxia ou tratamento de asma e/ou bronquite, de rinite, de alergia, e, de incontinência urinária BR9809713A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14180597 1997-05-30
PCT/JP1998/002308 WO1998054191A1 (fr) 1997-05-30 1998-05-27 Sels de derive de sulfoxyde optiquement actif

Publications (1)

Publication Number Publication Date
BR9809713A true BR9809713A (pt) 2000-07-11

Family

ID=15300548

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809713-0A BR9809713A (pt) 1997-05-30 1998-05-27 Composto, medicamento e composição compreendendo o mesmo, uso do composto, e, processos para profilaxia ou tratamento de doenças mediadas com taquicinina, para inibir um receptor nk1 e/ou um receptor nk2, e para profilaxia ou tratamento de asma e/ou bronquite, de rinite, de alergia, e, de incontinência urinária

Country Status (23)

Country Link
US (1) US6362179B1 (pt)
EP (1) EP0987269B1 (pt)
KR (1) KR100432210B1 (pt)
CN (1) CN1153773C (pt)
AT (1) ATE247122T1 (pt)
AU (1) AU732384B2 (pt)
BR (1) BR9809713A (pt)
CA (1) CA2290392C (pt)
CZ (1) CZ296599B6 (pt)
DE (1) DE69817178T2 (pt)
DK (1) DK0987269T3 (pt)
ES (1) ES2202853T3 (pt)
HK (1) HK1025321A1 (pt)
HU (1) HUP0002459A3 (pt)
ID (1) ID23697A (pt)
IL (2) IL132962A0 (pt)
NO (1) NO995847L (pt)
NZ (2) NZ513904A (pt)
PL (1) PL193115B1 (pt)
PT (1) PT987269E (pt)
RU (1) RU2190615C2 (pt)
TR (1) TR199902943T2 (pt)
WO (1) WO1998054191A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID25477A (id) 1998-01-23 2000-10-05 Sankyo Co Turunan-turunan spiropiperidin
WO2002051440A1 (fr) * 2000-12-22 2002-07-04 Takeda Chemical Industries, Ltd. Medicaments de combinaison

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0680607A4 (en) 1993-01-22 1997-06-04 Adeza Biomedical Corp ASSAY METHOD FOR IDENTIFYING BREAKAGE OF MEMBRANES IN WOMEN AT RISK OF IMMINENT DELIVERY.
CN1081635C (zh) 1993-05-06 2002-03-27 默里尔药物公司 取代的吡咯烷 -3-基-烷基-哌啶
EP0702681A1 (en) 1993-06-07 1996-03-27 Merck & Co. Inc. Spiro-substituted azacycles as neurokinin antagonists
WO1995028389A1 (fr) * 1994-04-15 1995-10-26 Yamanouchi Pharmaceutical Co., Ltd. Compose spiro et composition medicinale issue de ce compose
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
RU2135494C1 (ru) 1995-12-01 1999-08-27 Санкио Компани Лимитед Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина
JP3088672B2 (ja) * 1995-12-01 2000-09-18 三共株式会社 飽和複素環化合物

Also Published As

Publication number Publication date
TR199902943T2 (xx) 2000-05-22
WO1998054191A1 (fr) 1998-12-03
NO995847D0 (no) 1999-11-29
EP0987269A4 (en) 2001-07-11
AU732384B2 (en) 2001-04-26
KR20010012951A (ko) 2001-02-26
PL336894A1 (en) 2000-07-17
US6362179B1 (en) 2002-03-26
DE69817178D1 (de) 2003-09-18
IL132962A0 (en) 2001-03-19
NZ501332A (en) 2001-10-26
ID23697A (id) 2000-05-11
NO995847L (no) 2000-01-28
HUP0002459A2 (hu) 2001-06-28
KR100432210B1 (ko) 2004-05-20
IL132962A (en) 2007-06-17
DE69817178T2 (de) 2004-05-27
HUP0002459A3 (en) 2002-10-28
RU2190615C2 (ru) 2002-10-10
CA2290392A1 (en) 1998-12-03
HK1025321A1 (en) 2000-11-10
EP0987269A1 (en) 2000-03-22
PL193115B1 (pl) 2007-01-31
ATE247122T1 (de) 2003-08-15
AU7451598A (en) 1998-12-30
CN1264383A (zh) 2000-08-23
CN1153773C (zh) 2004-06-16
CA2290392C (en) 2006-03-28
ES2202853T3 (es) 2004-04-01
CZ296599B6 (cs) 2006-04-12
EP0987269B1 (en) 2003-08-13
DK0987269T3 (da) 2003-10-06
NZ513904A (en) 2001-09-28
PT987269E (pt) 2003-11-28
CZ419599A3 (cs) 2000-03-15

Similar Documents

Publication Publication Date Title
HUP9603298A3 (en) Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation, and their use for the preparation of pharmaceutical compositions
WO1995031985A3 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
DE69414398D1 (de) Heterocyclische neurokinin-antagonisten
WO2000064441A3 (en) Compound for use as a medicament for treatment of disorders involving bronchocontraction
HUT76644A (en) Substituted piperidines, pharmaceutical compositions containing them and their use
MY137535A (en) New pyrrolidinium derivatives
GEP20063958B (en) 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
TR200001942T2 (tr) Opioid agonist/antagonist kombinasyonlar
YU60696A (sh) Dihidropirimidini i njihova primena
DE60203797D1 (de) Benzo[d]azepin-derivative als 5-ht6-rezeptor-antagonisten
CA2378613A1 (en) Selective iglur5 receptor antagonists for the treatment of migraine
CA2284551A1 (en) New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders
WO1997010824A8 (en) Use of 5ht1b receptor antagonist for the treatment of vascular disease
WO2004096118A3 (en) Composition for improving cognition and memory
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
BR9809713A (pt) Composto, medicamento e composição compreendendo o mesmo, uso do composto, e, processos para profilaxia ou tratamento de doenças mediadas com taquicinina, para inibir um receptor nk1 e/ou um receptor nk2, e para profilaxia ou tratamento de asma e/ou bronquite, de rinite, de alergia, e, de incontinência urinária
NZ535611A (en) Pharmaceutical composition of a PDE4 or a PDE3/4 inhibitor and a histamine receptor antagonist
IL108784A0 (en) Use of 2h-1,2,4-benzothiadiazin-3(4h)-one 1,1-dioxide derivatives as noncompetitive antagonists of the mmda receptor
BR9812404A (pt) Combinação de um antagonista de endotelina, preparação farmacêutica, processo para preparar uma preparação farmacêutica, e , uso de uma combinação de um bloqueador de beta receptor e de um antagonista de endotelina
PT896822E (pt) 4-aminopirrolo (3,2-d)pirimidinas como antagonistas do receptor de neuropeptideo y
WO2000076500A8 (en) Compound for use as a medicament for treatment of disorders involving bronchocontraction
PT1244438E (pt) Utilizacao de antagonistas dos receptores beta-adrenergicos para o fabrico de um medicamento destinado ao tratamento de perturbacoes da retina externa
WO1998004289A3 (en) Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist
HUP9702149A3 (en) Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
DE69505351T2 (de) Zyklische neurokinin a - antagonisten

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.